Pan-glioma analysis revealed association of MAGEH1 with better survival in both, REMBRANDT (HR=2.92, 95% CI=2.3–3.71, p<0.001, Figure 5A) and TCGA dataset (HR=5.76, 95% CI=4.39–7.55, p<0.001, Figure 5B). This evidence concerns the gene MAGEH1 and glioma.